Opioid System and Epithelial-Mesenchymal Transition.

Area of Science:

• Oncology
• Pharmacology
• Cell Biology

Background:

• Opioids are essential analgesics, particularly for cancer patients, but carry risks like dependency and constipation.
• Opioid use is linked to immunosuppression, tumor progression, and impaired tissue regeneration, complicating cancer treatment and wound healing.
• Recent research explores the complex relationship between opioids and epithelial-mesenchymal transition (EMT) in cancer.

Purpose of the Study:

• To summarize current findings on how opioids influence epithelial-mesenchymal transition (EMT) in cancer.
• To identify factors governing opioid-mediated EMT induction or repression.
• To highlight the need for further research into opioid-EMT interactions for improved cancer patient prognosis.

Main Methods:

• Literature review of existing studies on opioid use, cancer, and EMT.
• Analysis of clinical data and experimental findings linking opioid administration to EMT.
• Synthesis of evidence to understand the dual role of opioids in EMT processes.

Main Results:

• Opioids can either promote or inhibit EMT depending on specific clinical conditions and patient factors.
• EMT, crucial for wound healing, becomes detrimental in cancer progression and fibrogenesis when induced by opioids.
• The precise mechanisms and conditions dictating opioid effects on EMT require further elucidation.

Conclusions:

• Opioid-mediated EMT modulation presents a significant challenge in cancer care.
• Tailoring opioid treatment strategies based on their impact on EMT is necessary to mitigate negative effects on disease outcome.
• Further investigation is essential to fully understand and leverage the opioid-EMT relationship for therapeutic benefit in cancer patients.